Literature DB >> 19759517

Restimulation-induced apoptosis of T cells is impaired in patients with X-linked lymphoproliferative disease caused by SAP deficiency.

Andrew L Snow1, Rebecca A Marsh, Scott M Krummey, Philip Roehrs, Lisa R Young, Kejian Zhang, Jack van Hoff, Deepali Dhar, Kim E Nichols, Alexandra H Filipovich, Helen C Su, Jack J Bleesing, Michael J Lenardo.   

Abstract

X-linked lymphoproliferative disease (XLP) is a rare congenital immunodeficiency that leads to an extreme, usually fatal increase in the number of lymphocytes upon infection with EBV. It is most commonly defined molecularly by loss of expression of SLAM-associated protein (SAP). Despite this, there is little understanding of how SAP deficiency causes lymphocytosis following EBV infection. Here we show that T cells from individuals with XLP are specifically resistant to apoptosis mediated by TCR restimulation, a process that normally constrains T cell expansion during immune responses. Expression of SAP and the SLAM family receptor NK, T, and B cell antigen (NTB-A) were required for TCR-induced upregulation of key pro-apoptotic molecules and subsequent apoptosis. Further, SAP/NTB-A signaling augmented the strength of the proximal TCR signal to achieve the threshold required for restimulation-induced cell death (RICD). Strikingly, TCR ligation in activated T cells triggered increased recruitment of SAP to NTB-A, dissociation of the phosphatase SHP-1, and colocalization of NTB-A with CD3 aggregates. In contrast, NTB-A and SHP-1 contributed to RICD resistance in XLP T cells. Our results reveal what we believe to be novel roles for NTB-A and SAP in regulating T cell homeostasis through apoptosis and provide mechanistic insight into the pathogenesis of lymphoproliferative disease in XLP.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19759517      PMCID: PMC2752081          DOI: 10.1172/JCI39518

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  45 in total

Review 1.  X-linked lymphoproliferative disease: clinical, diagnostic and molecular perspective.

Authors:  Hubert B Gaspar; Reza Sharifi; Kimberly C Gilmour; Adrian J Thrasher
Journal:  Br J Haematol       Date:  2002-12       Impact factor: 6.998

2.  SAP controls T cell responses to virus and terminal differentiation of TH2 cells.

Authors:  C Wu; K B Nguyen; G C Pien; N Wang; C Gullo; D Howie; M R Sosa; M J Edwards; P Borrow; A R Satoskar; A H Sharpe; C A Biron; C Terhorst
Journal:  Nat Immunol       Date:  2001-05       Impact factor: 25.606

3.  Molecular dissection of the signaling and costimulatory functions of CD150 (SLAM): CD150/SAP binding and CD150-mediated costimulation.

Authors:  Duncan Howie; María Simarro; Joan Sayos; Maria Guirado; Jaime Sancho; Cox Terhorst
Journal:  Blood       Date:  2002-02-01       Impact factor: 22.113

4.  A "three-pronged" binding mechanism for the SAP/SH2D1A SH2 domain: structural basis and relevance to the XLP syndrome.

Authors:  Peter M Hwang; Chengjun Li; Massimo Morra; Jennifer Lillywhite; D Ranjith Muhandiram; Frank Gertler; Cox Terhorst; Lewis E Kay; Tony Pawson; Julie D Forman-Kay; Shun-Cheng Li
Journal:  EMBO J       Date:  2002-02-01       Impact factor: 11.598

5.  A common E2F-1 and p73 pathway mediates cell death induced by TCR activation.

Authors:  N A Lissy; P K Davis; M Irwin; W G Kaelin; S F Dowdy
Journal:  Nature       Date:  2000-10-05       Impact factor: 49.962

Review 6.  The many roles of FAS receptor signaling in the immune system.

Authors:  Andreas Strasser; Philipp J Jost; Shigekazu Nagata
Journal:  Immunity       Date:  2009-02-20       Impact factor: 31.745

7.  TCR ligand discrimination is enforced by competing ERK positive and SHP-1 negative feedback pathways.

Authors:  Irena Stefanová; Bernhard Hemmer; Marco Vergelli; Roland Martin; William E Biddison; Ronald N Germain
Journal:  Nat Immunol       Date:  2003-02-10       Impact factor: 25.606

8.  Mice deficient in the X-linked lymphoproliferative disease gene sap exhibit increased susceptibility to murine gammaherpesvirus-68 and hypo-gammaglobulinemia.

Authors:  Luo Yin; Umaima Al-Alem; Jun Liang; Wei-Min Tong; Cuiling Li; Manuela Badiali; Jean Jacques Médard; Janos Sumegi; Zhao-Qi Wang; Giovanni Romeo
Journal:  J Med Virol       Date:  2003-11       Impact factor: 2.327

9.  Functional requirements for interactions between CD84 and Src homology 2 domain-containing proteins and their contribution to human T cell activation.

Authors:  Stuart G Tangye; Kim E Nichols; Nathan J Hare; Barbara C M van de Weerdt
Journal:  J Immunol       Date:  2003-09-01       Impact factor: 5.422

10.  NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease.

Authors:  C Bottino; M Falco; S Parolini; E Marcenaro; R Augugliaro; S Sivori; E Landi; R Biassoni; L D Notarangelo; L Moretta; A Moretta
Journal:  J Exp Med       Date:  2001-08-06       Impact factor: 14.307

View more
  59 in total

1.  Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop.

Authors:  Joao B Oliveira; Jack J Bleesing; Umberto Dianzani; Thomas A Fleisher; Elaine S Jaffe; Michael J Lenardo; Frederic Rieux-Laucat; Richard M Siegel; Helen C Su; David T Teachey; V Koneti Rao
Journal:  Blood       Date:  2010-06-10       Impact factor: 22.113

Review 2.  New advances in the diagnosis and treatment of autoimmune lymphoproliferative syndrome.

Authors:  David T Teachey
Journal:  Curr Opin Pediatr       Date:  2012-02       Impact factor: 2.856

3.  Positive and negative signaling through SLAM receptors regulate synapse organization and thresholds of cytolysis.

Authors:  Fang Zhao; Jennifer L Cannons; Mala Dutta; Gillian M Griffiths; Pamela L Schwartzberg
Journal:  Immunity       Date:  2012-06-07       Impact factor: 31.745

Review 4.  Updated Understanding of Autoimmune Lymphoproliferative Syndrome (ALPS).

Authors:  Pu Li; Ping Huang; Ye Yang; Mu Hao; Hongwei Peng; Fei Li
Journal:  Clin Rev Allergy Immunol       Date:  2016-02       Impact factor: 8.667

5.  ALPS-ten lessons from an international workshop on a genetic disease of apoptosis.

Authors:  Michael J Lenardo; João B Oliveira; Lixin Zheng; V Koneti Rao
Journal:  Immunity       Date:  2010-03-26       Impact factor: 31.745

6.  XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease.

Authors:  Rebecca A Marsh; Lisa Madden; Brenda J Kitchen; Rajen Mody; Brad McClimon; Michael B Jordan; Jack J Bleesing; Kejian Zhang; Alexandra H Filipovich
Journal:  Blood       Date:  2010-05-20       Impact factor: 22.113

7.  Inducible T Cell Kinase Regulates the Acquisition of Cytolytic Capacity and Degranulation in CD8+ CTLs.

Authors:  Senta M Kapnick; Jane C Stinchcombe; Gillian M Griffiths; Pamela L Schwartzberg
Journal:  J Immunol       Date:  2017-02-17       Impact factor: 5.422

8.  Protein phosphatase 2A B55β limits CD8+ T cell lifespan following cytokine withdrawal.

Authors:  Noé Rodríguez-Rodríguez; Iris K Madera-Salcedo; J Alejandro Cisneros-Segura; H Benjamín García-González; Sokratis A Apostolidis; Abril Saint-Martin; Marcela Esquivel-Velázquez; Tran Nguyen; Dámaris P Romero-Rodríguez; George C Tsokos; Jorge Alcocer-Varela; Florencia Rosetti; José C Crispín
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

Review 9.  Pediatric hemophagocytic lymphohistiocytosis.

Authors:  Scott W Canna; Rebecca A Marsh
Journal:  Blood       Date:  2020-04-16       Impact factor: 22.113

Review 10.  Metabolic reprogramming and apoptosis sensitivity: Defining the contours of a T cell response.

Authors:  Kelsey Voss; Sasha E Larsen; Andrew L Snow
Journal:  Cancer Lett       Date:  2017-09-01       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.